Nathan P. Coussens

2.9k total citations
47 papers, 1.8k citations indexed

About

Nathan P. Coussens is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Nathan P. Coussens has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Nathan P. Coussens's work include Computational Drug Discovery Methods (6 papers), DNA Repair Mechanisms (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Nathan P. Coussens is often cited by papers focused on Computational Drug Discovery Methods (6 papers), DNA Repair Mechanisms (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Nathan P. Coussens collaborates with scholars based in United States, Netherlands and France. Nathan P. Coussens's co-authors include Anton Simeonov, S. Ramaswamy, Ajit Jadhav, Matthew D. Hall, Lawrence E. Samelson, Lakshmi Balagopalan, Adam Yasgar, Jerrold Weiss, Theresa L. Gioannini and Desheng Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Nathan P. Coussens

45 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan P. Coussens United States 18 969 522 234 114 114 47 1.8k
Guodong Hu China 21 912 0.9× 254 0.5× 246 1.1× 59 0.5× 60 0.5× 86 1.5k
Cordelia Schiene‐Fischer Germany 29 1.5k 1.6× 431 0.8× 358 1.5× 108 0.9× 61 0.5× 53 2.1k
Jaume Pons United States 31 1.6k 1.7× 764 1.5× 497 2.1× 123 1.1× 46 0.4× 65 3.2k
Nina M. Haste United States 23 1.9k 2.0× 328 0.6× 229 1.0× 175 1.5× 129 1.1× 29 2.8k
Bernd Becker Germany 26 1.2k 1.3× 413 0.8× 402 1.7× 131 1.1× 88 0.8× 41 2.1k
Michael D. W. Griffin Australia 32 2.0k 2.1× 379 0.7× 389 1.7× 122 1.1× 32 0.3× 122 3.1k
Jon C. D. Houtman United States 29 1.2k 1.3× 769 1.5× 320 1.4× 115 1.0× 35 0.3× 78 2.4k
Carmelo Di Primo France 28 1.3k 1.4× 217 0.4× 129 0.6× 293 2.6× 67 0.6× 71 2.1k
J. Brandon Parker United States 24 1.0k 1.1× 191 0.4× 323 1.4× 103 0.9× 60 0.5× 37 1.9k
Christie G. Brouillette United States 29 2.6k 2.6× 204 0.4× 274 1.2× 133 1.2× 151 1.3× 57 3.7k

Countries citing papers authored by Nathan P. Coussens

Since Specialization
Citations

This map shows the geographic impact of Nathan P. Coussens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan P. Coussens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan P. Coussens more than expected).

Fields of papers citing papers by Nathan P. Coussens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan P. Coussens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan P. Coussens. The network helps show where Nathan P. Coussens may publish in the future.

Co-authorship network of co-authors of Nathan P. Coussens

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan P. Coussens. A scholar is included among the top collaborators of Nathan P. Coussens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan P. Coussens. Nathan P. Coussens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dexheimer, Thomas S., Nathan P. Coussens, Raymond G. Fox, et al.. (2025). RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types. Cancer Research Communications. 5(10). 1779–1795.
2.
Dexheimer, Thomas S., Nathan P. Coussens, Thomas Silvers, et al.. (2025). Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids. SLAS DISCOVERY. 32. 100222–100222. 2 indexed citations
3.
Košek, Dalibor, Stewart R. Durell, Lisa M. Jenkins, et al.. (2024). Crystal structure and mechanistic studies of the PPM1D serine/threonine phosphatase catalytic domain. Journal of Biological Chemistry. 300(8). 107561–107561. 1 indexed citations
4.
Kunkel, Mark W., Nathan P. Coussens, Joel Morris, et al.. (2024). HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer Research. 84(15). 2403–2416. 11 indexed citations
5.
Coussens, Nathan P., Thomas S. Dexheimer, Eric M. Jones, et al.. (2024). Abstract 3090: Development and performance of the National Cancer Institute’s HTS384 NCI60 screen: A modernized platform to support drug discovery and development by the worldwide cancer research community. Cancer Research. 84(6_Supplement). 3090–3090. 1 indexed citations
6.
Dexheimer, Thomas S., Nathan P. Coussens, Eric A. Jones, et al.. (2024). Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor. SLAS DISCOVERY. 29(7). 100186–100186. 3 indexed citations
7.
Dexheimer, Thomas S., Thomas Silvers, Nathan P. Coussens, et al.. (2024). Abstract 4608: Combinations of Cdc-like kinase (CLK) inhibitors with targeted oncology agents or standard chemotherapy in patient-derived multi-cell type tumor spheroids. Cancer Research. 84(6_Supplement). 4608–4608.
8.
Kales, Stephen C., Natarajan V. Bhanu, Ying Xiong, et al.. (2023). Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase Inhibitors. ACS Chemical Biology. 18(10). 2249–2258. 4 indexed citations
9.
Dexheimer, Thomas S., Nathan P. Coussens, John Wright, et al.. (2023). Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs. Cancer Research Communications. 3(8). 1648–1661. 6 indexed citations
10.
Sun, Hongmao, Nathan P. Coussens, Carina Danchik, et al.. (2022). Discovery of Small-Molecule VapC1 Nuclease Inhibitors by Virtual Screening and Scaffold Hopping from an Atomic Structure Revealing Protein–Protein Interactions with a Native VapB1 Inhibitor. Journal of Chemical Information and Modeling. 62(5). 1249–1258. 3 indexed citations
11.
Fang, Yuhong, Dingyin Tao, Hongmao Sun, et al.. (2022). Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen. ACS Pharmacology & Translational Science. 5(10). 993–1006. 7 indexed citations
12.
Jian, Xiaoying, Olivier Soubias, Peng Zhai, et al.. (2019). Interaction of the N terminus of ADP-ribosylation factor with the PH domain of the GTPase-activating protein ASAP1 requires phosphatidylinositol 4,5-bisphosphate. Journal of Biological Chemistry. 294(46). 17354–17370. 8 indexed citations
13.
Kashipathy, M.M., Scott Lovell, K.P. Battaile, et al.. (2019). Crystal Structure of VapBC-1 from Nontypeable Haemophilus influenzae and the Effect of PIN Domain Mutations on Survival during Infection. Journal of Bacteriology. 201(12). 4 indexed citations
14.
Martinez, Natalia J., Alexey Zakharov, Daniel J. Urban, et al.. (2018). A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase. Scientific Reports. 8(1). 9472–9472. 63 indexed citations
15.
Coussens, Nathan P., et al.. (2018). Better living through chemistry: Addressing emerging antibiotic resistance. Experimental Biology and Medicine. 243(6). 538–553. 9 indexed citations
16.
Stafford, William C., Xiaoxiao Peng, Maria Hägg Olofsson, et al.. (2018). Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Science Translational Medicine. 10(428). 164 indexed citations
17.
Coussens, Nathan P., Stephen C. Kales, Mark J. Henderson, et al.. (2018). High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2. Journal of Biological Chemistry. 293(35). 13750–13765. 55 indexed citations
18.
Coussens, Nathan P., John Braisted, Tyler Peryea, et al.. (2017). Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs. Pharmacological Reviews. 69(4). 479–496. 56 indexed citations
19.
Coussens, Nathan P., François‐Xavier Gallat, Koichiro J. Yagi, et al.. (2016). Structure of a heterogeneous, glycosylated, lipid-bound,in vivo-grown protein crystal at atomic resolution from the viviparous cockroachDiploptera punctata. IUCrJ. 3(4). 282–293. 20 indexed citations
20.
Johnston, Jason W., Nathan P. Coussens, Simon Allen, et al.. (2007). Characterization of the N-Acetyl-5-neuraminic Acid-binding Site of the Extracytoplasmic Solute Receptor (SiaP) of Nontypeable Haemophilus influenzae Strain 2019. Journal of Biological Chemistry. 283(2). 855–865. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026